Welcome to our dedicated page for The Oncology Institute news (Ticker: TOI), a resource for investors and traders seeking the latest updates and insights on The Oncology Institute stock.
The Oncology Institute Inc (TOI) delivers community-focused cancer care through innovative treatment models and value-based services. This page serves as the definitive source for official company announcements, financial updates, and strategic developments.
Access real-time updates on TOI's clinical trial advancements, partnership agreements, and operational milestones. Investors will find earnings reports, leadership updates, and market-moving news consolidated for efficient analysis. Media professionals can track press releases detailing TOI's expansion of outpatient services and community health initiatives.
Key content categories include quarterly financial disclosures, research collaborations, care model innovations, and regulatory developments. All materials are sourced directly from TOI's corporate communications, ensuring accuracy and timeliness.
Bookmark this page for streamlined access to TOI's evolving story in oncology care. Check regularly for updates that matter to stakeholders monitoring the intersection of healthcare innovation and value-based treatment delivery.
The Oncology Institute of Hope and Innovation (NASDAQ: TOI) has announced the promotions of Dr. Daniel Virnich to President and Dr. Matt Miller to Chief Operating Officer, effective March 15, 2022. These changes are part of a response to TOI's rapid growth. Dr. Virnich, who joined in 2020, will oversee various functions including Operations and Compliance, while Dr. Miller will manage all field and central operations nationally. Both leaders have previously driven tangible improvements in operational efficiency and patient satisfaction, positioning TOI for continued development in specialized oncology care.
The Oncology Institute (TOI) has established a value-based agreement with MaxHealth to deliver medical oncology care in Pinellas and Hillsborough Counties, beginning March 1, 2022. This partnership aims to enhance patient care through TOI's innovative oncology model, which includes over 170 clinical trials and comprehensive oncology services. The initiative targets expansion into neighboring counties, reflecting TOI's commitment to improving cancer care accessibility. Both organizations emphasize a shared goal of personalized patient care and satisfaction.
The Oncology Institute of Hope and Innovation (TOI) has entered a value-based agreement with MaxHealth to provide medical oncology care in Pinellas and Hillsborough Counties, Florida. This partnership, effective from March 1, 2022, aims to enhance cancer care access and quality through community-focused services, including clinical trials and stem cell transplants. TOI plans to expand this initiative to neighboring counties shortly. Both organizations emphasize a commitment to personalized care and improving patient satisfaction.
The Oncology Institute (TOI) will release its fourth quarter and full year results on March 10, 2022, after market close. Following the results, a conference call is scheduled for 5:00 p.m. ET, accessible via phone or webcast. TOI specializes in delivering advanced, value-based cancer care to over 1.5 million patients, with 54 clinic locations and a team of 80+ clinicians. Their services include clinical trials, stem cell transplants, and transfusions. Interested parties can join the call and access a replay through the provided contact information.
The Oncology Institute of Hope and Innovation (NASDAQ: TOI) has expanded its footprint by opening its 54th clinic in Lakeland, Florida, enhancing oncology services available in Polk County. This new clinic, which is the sixth in Florida, aims to provide patients with convenient access to oral chemotherapeutics and blood transfusion services. With experienced providers onboard, the institute continues to showcase its commitment to value-based cancer care. The expansion aligns with TOI's efforts to elevate healthcare standards and meet growing patient needs in the region.
TOI has expanded its physician network by acquiring the practices of Dr. Ellsworth R. Grant and Dr. Leo E. Orr, adding to its team of over 80 clinicians. This acquisition will enhance TOI's ability to provide value-based oncology care to more than 1.5 million patients across its locations.
The new facility in Westlake offers advanced medical services similar to other TOI clinics, enhancing patient access to high-quality cancer care.
The Oncology Institute (TOI) has successfully completed its business combination with DFP Healthcare Acquisitions Corp., with approval received on November 12, 2021.
This merger, now valued at $842 million, enables TOI to retain approximately $133 million for growth initiatives. TOI’s stock began trading on NASDAQ under the symbols 'TOI' and 'TOIIW'. With a history of providing high-quality cancer care to over 150,000 patients across four states, TOI aims to disrupt the $200 billion U.S. oncology market through a value-based care model.
The Oncology Institute (NASDAQ: TOI) has completed its fourth acquisition in Q4 by acquiring the practice of Dr. Honghao Yang and his two oncology clinics in California. This expands TOI's coverage in the San Gabriel Valley, complementing its existing locations. Dr. Yang has over 30 years of experience and is recognized for his patient care approach. The new clinics will have multilingual staff to serve diverse communities. TOI aims to enhance its operational capacity and patient services through this integration.
The Oncology Institute (TOI) has successfully completed its merger with DFP Healthcare Acquisitions Corp., with the transaction approved on November 12, 2021. This merger establishes TOI as a public company, trading under the new ticker symbols 'TOI' and 'TOIIW' on NASDAQ. The transaction values TOI at $842 million, with a significant cash infusion of approximately $334 million, including $275 million from a private placement. The funds will support expansion initiatives across multiple states, driving TOI's value-based oncology care strategy.
FAQ
What is the current stock price of The Oncology Institute (TOI)?
What is the market cap of The Oncology Institute (TOI)?
